IHH Healthcare and Fortis announce winners of Inaugural IHH Catalyst
July 03, 2026 | Friday | News
Top three winners selected from 10 high-potential healthcare startups shortlisted from 195 applications across India
IHH Healthcare, the world’s leading multinational healthcare provider, together with its subsidiary Fortis Healthcare, has announced the winners of the inaugural IHH Catalyst | Fortis India Edition, marking a significant step towards accelerating healthcare innovation and entrepreneurship in India.
At the IHH Catalyst | Fortis India Edition Demo Day, 10 high-potential healthcare startups presented their solutions before an eminent jury comprising healthcare leaders, clinicians, investors and industry experts, following a structured 12-week accelerator programme involving mentorship, clinical validation, operational refinement and real-world testing opportunities within the Fortis ecosystem.
The startups were declared winners based on evaluation across four key criteria: team, level of innovation, impact and scalability, and business potential. The framework recognised startups demonstrating strong clinical relevance, implementation readiness and the potential to address real-world healthcare challenges at scale.
Winners of IHH Catalyst | Fortis India Edition 2026
Winner: eNext ICU – The startup is addressing the critical shortage of intensivists, particularly in Tier-2 and Tier-3 cities, through a 24×7 Tele-ICU platform that enables remote monitoring and management of critically-ill patients by experienced specialists.
First Runner-Up: RNT Health Insights – The startup is developing AI-powered medical devices that enhance the early detection of upper gastrointestinal (GI) cancers during routine endoscopic procedures.
Second Runner-Up: Cartogene Therapeutics – The startup is making advanced CAR-T cell therapy more accessible and affordable for patients with blood cancers in India.
Launched in February, this year as the first regional edition of IHH Healthcare’s global incubator platform, the programme received an overwhelming response from the healthcare startup ecosystem, attracting 195 applications from across India. Following a rigorous multi-stage evaluation process, 10 startups were selected for the inaugural cohort.
The ten startups selected for the inaugural cohort were:
- Cartogene Therapeutics
- CarePal Money
- Tatvacare
- MicroHeal
- RNT Health Insights
- Nalagenetics
- Sunfox Technologies
- eNext ICU
- Kubo Care
- Cureous Labs
Collectively, the inaugural cohort showcased promising innovations across the programme’s five priority areas, spanning patient journey and workflows, preventative and predictive care, chronic disease management, multidisciplinary care and oncology. Together, they reflect the breadth of healthcare innovation progressing towards clinical validation and real-world adoption within the Fortis ecosystem.
Throughout the programme, startups worked closely with Fortis clinicians, operational leaders and functional experts to refine their solutions, validate use cases, and explore pathways for deployment within real healthcare environments. The programme provided access to mentorship, clinical expertise, hospital infrastructure, regulatory guidance, cybersecurity frameworks, interoperability support, and commercialisation pathways.
